Valuation: Hofseth BioCare ASA

Market Cap 689M 73.01M 64.9M 60.15M 54.73M 103M 6.93B 105M 723M 283M 3.62B 274M 268M 11.53B P/E 2024
-5.58x
P/E 2025 -4x
Enterprise Value 982M 104M 92.47M 85.71M 77.98M 147M 9.87B 150M 1.03B 404M 5.15B 390M 382M 16.42B EV / Sales 2024
3.18x
EV / Sales 2025 3.26x
Free-Float
74.84%
Yield 2024 *
-
Yield 2025 -
1 day-1.49%
1 week-4.00%
1 month-0.75%
3 months-8.01%
6 months+4.76%
1 week 1.25
Extreme 1.25
1.48
1 month 1.14
Extreme 1.145
1.5
Current year 1.1
Extreme 1.1
2.01
1 year 1.1
Extreme 1.1
2.1
3 years 1.1
Extreme 1.1
3.6
5 years 1.1
Extreme 1.1
7.7
10 years 1.1
Extreme 1.1
10.95
Manager TitleAgeSince
Chief Executive Officer 53 31/07/2022
Director of Finance/CFO - 31/08/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 30/04/2015
Director/Board Member - -
Director/Board Member - 02/12/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/07/23 Buy 74,000 0.0187%
28/02/23 Buy

Chief Technology Officer

200,000 0.0506%
17/02/23 Buy

Director

100,000 0.0253%
Change 5-day change 1-year change 3-year change Capi.($)
-1.49%-4.00%-34.98%-52.86% 73.01M
+1.68%+8.40%-2.83%-19.80% 257B
+1.40%+5.79%+2.32%+0.58% 81.57B
0.00%+0.08%+22.14%+540.13% 45.82B
+0.56%+4.87%-20.59%+13.08% 44.55B
-0.39%+3.40%+30.44%+9.85% 39.81B
+1.27%+4.97%-9.01%-10.45% 34.32B
+0.82%-2.20%+26.74%+84.36% 31.92B
+0.70%+2.82%-11.41%-5.10% 29.68B
+1.72%+6.33%-7.21%-24.85% 28.08B
Average +0.63%+2.70%-0.44%+53.49% 59.32B
Weighted average by Cap. +1.17%+5.43%+1.30%+37.35%

Financials

2024 2025
Net sales 266M 28.12M 25M 23.17M 21.08M 39.78M 2.67B 40.42M 279M 109M 1.39B 106M 103M 4.44B 256M 27.15M 24.13M 22.37M 20.35M 38.4M 2.58B 39.02M 269M 105M 1.34B 102M 99.72M 4.29B
Net income -125M -13.27M -11.8M -10.93M -9.95M -18.77M -1.26B -19.07M -131M -51.53M -657M -49.8M -48.74M -2.1B -135M -14.28M -12.7M -11.77M -10.71M -20.21M -1.36B -20.53M -141M -55.47M -707M -53.61M -52.47M -2.26B
Net Debt 145M 15.39M 13.68M 12.68M 11.54M 21.77M 1.46B 22.12M 152M 59.75M 762M 57.75M 56.52M 2.43B 293M 31.02M 27.57M 25.56M 23.25M 43.88M 2.94B 44.58M 307M 120M 1.54B 116M 114M 4.9B
Projected Income Statement - Annual - Hofseth BioCare ASA
Logo Hofseth BioCare ASA
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Employees
81
Date Price Change Volume
16/10/26 NOK 1.320 -1.49% 141,852
15/10/26 NOK 1.340 -0.37% 249,448
14/10/26 NOK 1.345 -1.10% 21,201
13/10/26 NOK 1.360 -2.86% 89,062
12/10/26 NOK 1.400 +1.82% 173,356